BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia
American Journal of Clinical Pathology · 2026
DOI: 10.1093/ajcp/aqag099 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Clinical Pathology, 2026. Verfasst von Jason Love und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States. Hauptthemen laut MEDLINE: Leukemia, Hairy Cell, Proto-Oncogene Proteins B-raf, Lymphoma, B-Cell, Marginal Zone. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
To establish the occurrence of BRAF mutation in marginal zone lymphomas (MZLs) and study its impact on clinical presentation, pathologic features, and disease classification.
Methods
Conventional histology, immunohistochemistry, flow cytometry, and molecular methods were used.
Results
We identified 2 BRAF‑mutated MZL cases: a nodal MZL (NMZL) with BRAF V600E and partial morphologic/immunophenotypic overlap with hairy cell leukemia (HCL) and an extranodal MZL with a non–V600E BRAF mutation co‑occurring with TET2, KRAS, and TP53 variants. The NMZL case showed strong CD25 and CD123 expression and patchy cyclin D1 expression; together with the presence of a BRAF V600E mutation, these features overlapped with HCL. However, the absence of annexin A1 and CD103 expression, along with the remaining morphologic features in the lymph node, supported accurate classification as NMZL.
Conclusions
These 2 cases expand the mutational spectrum of MZL and illustrate important diagnostic pitfalls. These observations underscore that BRAF V600E, while highly specific and clinically useful for HCL in the context of a B‑cell lymphoproliferative process involving blood and marrow, is not entirely pathognomonic and must be interpreted alongside morphology and a full immunophenotypic panel. Integrating BRAF testing into the workup of challenging small B‑cell lymphomas may refine diagnosis and reveal rare, potentially targetable MAPK pathway lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
- Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA, United States.
- Pathology Program, Translational Science & Therapeutics Division, Fred Hutchison Cancer Center, Seattle, WA, United States.
ORCID-Profile: Kikkeri N Naresh
Zitieren
APA
Love, J., Verma, T., Palmer, P., & Naresh, K. N. (2026). BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqag099
Vancouver
Love J, Verma T, Palmer P, Naresh KN. BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia. American Journal of Clinical Pathology. 2026. doi:10.1093/ajcp/aqag099
BibTeX
@article{Love2026,
author = {Love, Jason and Verma, Tanvi and Palmer, Phil and Naresh, Kikkeri N},
title = {BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia},
journal = {American Journal of Clinical Pathology},
year = {2026},
doi = {10.1093/ajcp/aqag099}
}
EUVIMED